Vivos Therapeutics v. Ortho-Tain

CourtCourt of Appeals for the Tenth Circuit
DecidedJune 21, 2022
Docket21-1309
StatusUnpublished

This text of Vivos Therapeutics v. Ortho-Tain (Vivos Therapeutics v. Ortho-Tain) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Vivos Therapeutics v. Ortho-Tain, (10th Cir. 2022).

Opinion

Appellate Case: 21-1309 Document: 010110699363 Date Filed: 06/21/2022 Page: 1 FILED United States Court of Appeals UNITED STATES COURT OF APPEALS Tenth Circuit

FOR THE TENTH CIRCUIT June 21, 2022 _________________________________ Christopher M. Wolpert Clerk of Court VIVOS THERAPEUTICS, INC.,

Plaintiff - Appellee,

v. No. 21-1309 (D.C. No. 1:20-CV-01634-WJM-SKC) ORTHO-TAIN, INC., (D. Colo.)

Defendant - Appellant. _________________________________

ORDER AND JUDGMENT* _________________________________

Before BACHARACH, BALDOCK, and EID, Circuit Judges. _________________________________

In this interlocutory appeal, Ortho-Tain, Inc. (OT), challenges a district court

order denying its motion to dismiss based in part on absolute immunity. OT also

invokes our pendent appellate jurisdiction to review other non-final rulings in the

district court’s order. To the extent the denial of immunity turns on a legal question,

we have jurisdiction under the collateral order doctrine and reverse and remand for

further proceedings. We dismiss the balance of the appeal for lack of jurisdiction.

* After examining the briefs and appellate record, this panel has determined unanimously to honor the parties’ request for a decision on the briefs without oral argument. See Fed. R. App. P. 34(f); 10th Cir. R. 34.1(G). The case is therefore submitted without oral argument. This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. It may be cited, however, for its persuasive value consistent with Fed. R. App. P. 32.1 and 10th Cir. R. 32.1. Appellate Case: 21-1309 Document: 010110699363 Date Filed: 06/21/2022 Page: 2

I. Background

The parties are competing manufacturers of dental devices. According to the

amended complaint and attached exhibits, in April 2020, OT’s CEO, Leslie Stevens,

sent a letter to Benco Dental Supply, which is an affiliate of Vivos Therapeutics, Inc.,

accusing Benco of hosting seminars where Vivos misrepresented OT’s products as its

own. In a series of communications that followed (collectively, the “Spring 2020

Communications”), OT’s lawyer, Nathan Neff, repeatedly stated that Vivos and

Benco were violating state and federal law, including the Lanham Act, 15 U.S.C.

§ 1125(a), which provides a cause of action for false advertising, see Bimbo Bakeries

USA, Inc. v. Sycamore, 29 F.4th 630, 643 (10th Cir. 2022). Neff demanded that

Benco notify seminar attendees of the alleged misrepresentations, cited legal

authority for OT’s position, and at least implicitly, if not explicitly, threatened legal

action. Indeed, on June 1, 2020, Neff sent Benco a draft complaint, which he later

filed (with revisions) in the Northern District of Illinois, naming Vivos and Benco as

defendants. And in a June 3 letter captioned, “Settlement Discussions – Lanham Act

Violations,” Aplt. App. at 224, Neff asserted he was “privileged to defame” so long

as his statements related to the proposed legal claims, id. at 226.

Vivos filed this suit several days later, asserting claims for libel per se, slander

per se, intentional interference with contractual relations, and declaratory relief that it

had not violated the Lanham Act. The following month, OT filed its complaint in the

Northern District of Illinois against Vivos, Benco, and others. Thereafter, the district

court here dismissed Vivos’s complaint with leave to amend. Meanwhile, in

2 Appellate Case: 21-1309 Document: 010110699363 Date Filed: 06/21/2022 Page: 3

December 2020, OT’s sales department sent emails (“December 2020 emails”) to

dentist-clients of Vivos, disparaging Vivos and its products. Consequently, when

Vivos filed its amended complaint, it reasserted its previous claims and added two

new claims for violations of the Lanham Act and the Colorado Consumer Protection

Act (CCPA). The following lists Vivos’s claims and the conduct upon which they

were predicated:

Count 1: Lanham Act based on the December 2020 emails (and other online material). Count 2: CCPA based on the December 2020 emails. Count 3: Libel per se based on the Spring 2020 Communications and the December 2020 emails. Count 4: Slander per se based on the Spring 2020 Communications. Count 5: Intentional interference with contractual relations based on the Spring 2020 Communications and the December 2020 emails. Count 6: Declaratory judgment that it had not violated the Lanham Act.

OT moved to dismiss, contending it had absolute immunity from any claims

based on the Spring 2020 Communications because they related to the Northern

District of Illinois litigation and as such were privileged. OT also argued that the

claims under the Lanham Act and the CCPA should be dismissed or stricken as

improper supplemental pleadings, that the entire amended complaint should be

dismissed for impermissibly incorporating allegations into subsequent counts, and

that the declaratory judgment claim should be dismissed as an improper anticipatory

filing intended to preempt the Northern District of Illinois litigation. The district

court rejected OT’s arguments, denied the motion to dismiss, and directed the parties

3 Appellate Case: 21-1309 Document: 010110699363 Date Filed: 06/21/2022 Page: 4

to schedule a status conference. Instead, OT filed this appeal. Vivos then moved to

dismiss this appeal for lack of jurisdiction. The parties have fully briefed the

jurisdictional and merits issues. The Northern District of Illinois litigation has been

stayed pending the outcome of this appeal and the underlying district court action or

until the Northern District of Illinois removes the stay.

I. Appellate Jurisdiction

We first consider our jurisdiction. Generally, an order denying immunity

qualifies for immediate review under the collateral order doctrine to the extent it

turns on an issue of law. See Mitchell v. Forsyth, 472 U.S. 511, 530 (1985). Indeed,

in Robinson v. Volkswagenwerk AG, we recognized that the collateral order doctrine

permits immediate appellate review of an interlocutory order denying a motion to

dismiss based on a claim of absolute immunity under the litigation privilege. See

940 F.2d 1369, 1370 (10th Cir. 1991). We therefore proceeded to the merits and

observed that “[a]ll lawyers are protected by an absolute privilege against defamation

actions based upon litigation conduct in judicial proceedings.” Id. at 1372.

OT invokes essentially the same litigation privilege recognized in Robinson.

Ordinarily, we would have jurisdiction to review this type of interlocutory appeal

from the district court’s denial of immunity.1 However, “[i]f a district court cannot

1 In challenging OT’s analogy to the qualified immunity context, Vivos contends the denial of immunity is not immediately appealable because OT’s assertion of immunity does not extend to all of its claims. See Mot. to Dismiss at 8-9; Mot. to Dismiss Reply Br. at 5-6.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Mitchell v. Forsyth
472 U.S. 511 (Supreme Court, 1985)
Behrens v. Pelletier
516 U.S. 299 (Supreme Court, 1996)
Weise v. Casper
507 F.3d 1260 (Tenth Circuit, 2007)
Buckhannon v. U.S. West Communications, Inc.
928 P.2d 1331 (Colorado Court of Appeals, 1996)
Club Valencia Homeowners Ass'n v. Valencia Associates
712 P.2d 1024 (Colorado Court of Appeals, 1985)
Department of Administration v. State Personnel Board
703 P.2d 595 (Colorado Court of Appeals, 1985)
Cummings v. Dean
913 F.3d 1227 (Tenth Circuit, 2019)
Begley v. Ireson
2017 COA 3 (Colorado Court of Appeals, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Vivos Therapeutics v. Ortho-Tain, Counsel Stack Legal Research, https://law.counselstack.com/opinion/vivos-therapeutics-v-ortho-tain-ca10-2022.